Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Simone H. Stahl"'
Autor:
Srinivasan Krishnan, Diane Ramsden, Douglas Ferguson, Simone H. Stahl, Joanne Wang, Dermot F. McGinnity, Niresh Hariparsad
Publikováno v:
Clinical Pharmacology & Therapeutics. 112:562-572
Transporters contribute to renal elimination of drugs; therefore drug disposition can be impacted if transporters are inhibited by comedicant drugs. Regulatory agencies have provided guidelines to assess potential drug-drug interaction (DDI) risk for
Autor:
Ian D. Wilson, Simone H. Stahl, Karla Lee, Isobelle Grant, Robert S. Plumb, Leanne C. Nye, Theo O. Dare, Andy Nicholls, Rebecca Dargue, Rajiv Jalan, Muireann Coen
Publikováno v:
Bioanalysis. 12:485-500
A U(H)PLC–MS/MS method is described for the analysis of acetaminophen and its sulphate, glucuronide, glutathione, cysteinyl and N-acetylcysteinyl metabolites in plasma using stable isotope-labeled internal standards. P-Aminophenol glucuronide and 3
Autor:
Kim L.R. Brouwer, Raymond Evers, Elizabeth Hayden, Shuiying Hu, Cindy Yanfei Li, Henriette E. Meyer zu Schwabedissen, Sibylle Neuhoff, Stefan Oswald, Micheline Piquette‐Miller, Chitra Saran, Noora Sjöstedt, Jason A. Sprowl, Simone H. Stahl, Wei Yue
Publikováno v:
Clinical pharmacology and therapeutics. 112(3)
Membrane transport proteins are involved in the absorption, disposition, efficacy, and/or toxicity of many drugs. Numerous mechanisms (e.g., nuclear receptors, epigenetic gene regulation, microRNAs, alternative splicing, post-translational modificati
Autor:
Pedro, Caetano-Pinto, Pär, Nordell, Tom, Nieskens, Katie, Haughan, Katherine S, Fenner, Simone H, Stahl
Publikováno v:
ALTEX.
Accurate prediction of pharmacokinetic parameters such as renal clearance is fundamental to the development of effective and safe new treatments for patients. However, conventional renal models have a limited ability to predict renal drug secretion,
Autor:
Pedro Caetano-Pinto, Katie Haughan, Angelique Kragl, Mladen V. Tzvetkov, Katherine S. Fenner, Simone H. Stahl
Publikováno v:
Organs-on-a-Chip. 4:100022
Autor:
Simone H. Stahl, Johan X. Johansson, Beth Williamson, Katherine Fenner, Ravindra V. Alluri, Jason Grant Kettle, M. Raymond V. Finlay
Publikováno v:
The Medicinal Chemist's Guide to Solving ADMET Challenges ISBN: 9781788012270
Membrane transporters are important determinants of cellular and tissue distribution of charged molecules. In the intestine, uptake transporters expressed at the apical membrane of enterocytes contribute to the dietary absorption of endogenous molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7579fba6de75407df41eb9b2bc4de65
https://doi.org/10.1039/9781788016414-00062
https://doi.org/10.1039/9781788016414-00062
Autor:
Martijn J. Wilmer, Ernst Ahlberg, Mikael Persson, Simone H. Stahl, Anna-Karin Sjögren, Malin Forsgard, Jorrit J. Hornberg, Lucas Milton, Katarina Breitholtz
Publikováno v:
Archives of Toxicology, 92, 3175-3190
Archives of Toxicology, 92, 10, pp. 3175-3190
Archives of Toxicology, 92, 10, pp. 3175-3190
Contains fulltext : 196765.pdf (Publisher’s version ) (Closed access) Drug-induced nephrotoxicity is a major concern in the clinic and hampers the use of available treatments as well as the development of innovative medicines. It is typically disco
Autor:
Simone H. Stahl, Pedro Caetano-Pinto
Publikováno v:
Drug Metabolism and Disposition. 46:1647-1657
Transmembrane flux of a drug within a tissue or organ frequently involves a complex system of transporters from multiple families that have redundant and overlapping specificities. Current in vitro systems poorly represent physiology, with reduced ex
Autor:
Simone H. Stahl, Christina Battista, Paul B. Watkins, Scott Q. Siler, Jerome T. Mettetal, Kyunghee Yang, Brett A. Howell
Publikováno v:
Toxicological Sciences
CKA, a chemokine receptor antagonist intended for treating inflammatory conditions, produced dose-dependent hepatotoxicity in rats but advanced into the clinic where single doses of CKA up to 600 mg appeared safe in humans. Because existing toxicolog
Autor:
Scott Q. Siler, Simone H. Stahl, Jeffrey L. Woodhead, Brett A. Howell, Christina Battista, Kyunghee Yang, Jerome T. Mettetal, Paul B. Watkins
Publikováno v:
Clinical Pharmacology and Therapeutics
Elevations in serum bilirubin during drug treatment may indicate global liver dysfunction and a high risk of liver failure. However, drugs also can increase serum bilirubin in the absence of hepatic injury by inhibiting specific enzymes/transporters.